Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

HKG:2563 Revenue

Beijing Biostar Pharmaceuticals had revenue of 7.39M CNY in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 53.53M. In the year 2024, Beijing Biostar Pharmaceuticals had annual revenue of 71.87M with 7.85% growth.

• Revenue (ttm): 53.53M CNY
• Revenue Growth: +7.85%
• P/S Ratio: 23.62
• Revenue / Employee: 408.63K CNY
• Employees: 131
• Market Cap: 1.39B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	71.87M	5.23M	7.85%
Dec 31, 2023	66.64M	33.82M	103.03%
Dec 31, 2022	32.82M	-38.24M	-53.82%
Dec 31, 2021	71.06M	-	-
Dec 31, 2020	-	-	-